@article{article, title = {{爆料公社 EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)鈥擳rial in progress.}}, publisher = {{American Society of Clinical Oncology (ASCO)}}, url = {{http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps582 }}, year = {{2023}}, month = {{2}}, author = {{Kamat AM and Steinberg GD and Inman BA and Kates MR and Uchio EM and Porten SP and Roupret M and Redorta J and Catto JWF and Kulkarni GS and Powles T et al}}, doi = {{10.1200/jco.2023.41.6_suppl.tps582}}, volume = {{41}}, journal = {{Journal of Clinical Oncology}}, issue = {{6_suppl}}, pages = {{TPS582-TPS582}}, note = {{Accessed on 2025/07/30}}}